WENDELL PHILLIPS: Open Payments
NPI 1598757114 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,459 in 24 payments from 11 companies in 2025. Trend: 2023 $1,881 · 2024 $1,413 · 2025 $2,459
Food & beverage: $2,459
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $1,064 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $247 |
| Novo Nordisk Inc | 2 | $230 |
| Stryker Corporation | 1 | $167 |
| ABBVIE INC. | 3 | $145 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Kowa Pharmaceuticals America, Inc. | 1 | $120 |
| Amgen Inc. | 1 | $119 |
| Braeburn Inc. | 1 | $110 |
| PFIZER INC. | 1 | $91 |
Products named: AIRSUPRA, BREZTRI, CAPLYTA, TEZSPIRE, FLOWTRIEVER CATHETER, S, LINZESS, REXULTI, Wegovy.
Industry payments across AZ — which companies pay providers there.
